Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will look at how the investigational dose of semaglutide works in helping people with excess body weight, to lose weight. This study will compare the weight loss in people taking semaglutide to people taking "dummy" medicine (placebo). The study will last for about 1 year. The participants will have 12 visits at the clinic and 3 remote visits by phone calls with the study doctor or staff.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For participants with T2D at screening:
Treated with either:
Exclusion criteria
For participants without T2D at screening:
For participants with T2D at screening:
Primary purpose
Allocation
Interventional model
Masking
242 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Novo Nordisk
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal